General Information of the Cell Line
Cell Line ID
CL000394
Cell Line Name
H9
Synonyms
HT clone H9
HT(H9)
H 9
H-9
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_1240
Tissue Information
Peripheral blood
Disease
Sezary syndrome (NCIt: C3366)
Sezary syndrome (ORDO: Orphanet_3162)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT00004, Pol polyprotein
Compound ID Compound Name Compound Formula
CP0113693
Aptivus
   Show/Hide
C31H33F3N2O5S
 1
1
IC50 = 30 nM
   TI
   LI
   LO
   TS
CP0811023
5-Cyano-pyridine-2-sulfonic acid {3-[1-((R)-4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C31H33N3O5S
 1
1
IC50 = 40 nM
   TI
   LI
   LO
   TS
CP0685136
5-Cyano-pyridine-2-sulfonic acid {3-[1-((S)-4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C31H33N3O5S
 1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0692315
5-Cyano-pyridine-2-sulfonic acid {3-[1-(4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C31H33N3O5S
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0808342
1-Methyl-1H-imidazole-4-sulfonic acid {3-[1-((R)-4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C29H35N3O5S
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0670346
5-Trifluoromethyl-pyridine-2-sulfonic acid {3-[1-((S)-4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C31H33F3N2O5S
 1
1
IC50 = 140 nM
   TI
   LI
   LO
   TS
CP0722620
5-Cyano-pyridine-2-sulfonic acid {3-[1-(4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-2,2-dimethyl-propyl]-phenyl}-amide
   Show/Hide
C33H37N3O5S
 1
1
IC50 = 140 nM
   TI
   LI
   LO
   TS
CP0771894
1-Methyl-1H-imidazole-4-sulfonic acid {3-[1-(4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-2,2-dimethyl-propyl]-phenyl}-amide
   Show/Hide
C31H39N3O5S
 1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0670345
5-Amino-pyridine-2-sulfonic acid {3-[1-(4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-2,2-dimethyl-propyl]-phenyl}-amide
   Show/Hide
C32H39N3O5S
 1
1
IC50 = 230 nM
   TI
   LI
   LO
   TS
CP0685123
5-Cyano-pyridine-2-sulfonic acid {3-[1-((R)-4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C31H33N3O5S
 1
1
IC50 = 490 nM
   TI
   LI
   LO
   TS
CP0713224
1-Methyl-1H-imidazole-4-sulfonic acid {3-[1-(4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C29H35N3O5S
 1
1
IC50 = 500 nM
   TI
   LI
   LO
   TS
CP0680926
5-Trifluoromethyl-pyridine-2-sulfonic acid {3-[1-(4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-2,2-dimethyl-propyl]-phenyl}-amide
   Show/Hide
C33H37F3N2O5S
 1
1
IC50 = 530 nM
   TI
   LI
   LO
   TS
CP0788411
1-Methyl-1H-imidazole-4-sulfonic acid {3-[1-((S)-4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C29H35N3O5S
 1
1
IC50 = 580 nM
   TI
   LI
   LO
   TS
CP0648742
1-Methyl-1H-imidazole-4-sulfonic acid {3-[1-(4-hydroxy-2-oxo-6,6-dipropyl-5,6-dihydro-2H-pyran-3-yl)-2,2-dimethyl-propyl]-phenyl}-amide
   Show/Hide
C26H37N3O5S
 1
1
IC50 = 600 nM
   TI
   LI
   LO
   TS
CP0683500
1-Methyl-1H-imidazole-4-sulfonic acid {3-[1-(4-hydroxy-2-oxo-6,6-diphenethyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C34H37N3O5S
 1
1
IC50 = 640 nM
   TI
   LI
   LO
   TS
CP0724036
1-Methyl-1H-imidazole-4-sulfonic acid [3-(1-{6-[2-(4-fluoro-phenyl)-ethyl]-4-hydroxy-2-oxo-6-propyl-5,6-dihydro-2H-pyran-3-yl}-propyl)-phenyl]-amide
   Show/Hide
C29H34FN3O5S
 1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS
CP0724374
1-Methyl-1H-imidazole-4-sulfonic acid {3-[1-(4-hydroxy-2-oxo-6,6-dipropyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C24H33N3O5S
 1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0658725
Quinoline-8-sulfonic acid {3-[1-(4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C34H36N2O5S
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0826059
1-Methyl-1H-imidazole-4-sulfonic acid {3-[1-(4-hydroxy-2-oxo-6,6-dipentyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C28H41N3O5S
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0674852
4-Cyano-N-{3-[1-(4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-benzenesulfonamide
   Show/Hide
C32H34N2O5S
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0654420
4-Cyano-N-{3-[1-(4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-2,2-dimethyl-propyl]-phenyl}-benzenesulfonamide
   Show/Hide
C34H38N2O5S
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0661213
4-Fluoro-N-{3-[1-(4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-benzenesulfonamide
   Show/Hide
C31H34FNO5S
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0661103
N-{3-[1-(4-Hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-benzenesulfonamide
   Show/Hide
C31H35NO5S
 1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0659942
1-Methyl-1H-imidazole-4-sulfonic acid (3-{1-[6,6-bis-(2-cyclopropyl-ethyl)-4-hydroxy-2-oxo-5,6-dihydro-2H-pyran-3-yl]-propyl}-phenyl)-amide
   Show/Hide
C28H37N3O5S
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0785301
1-Methyl-1H-imidazole-4-sulfonic acid {3-[1-(4-hydroxy-6,6-diisobutyl-2-oxo-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C26H37N3O5S
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0720021
5-Nitro-pyridine-2-sulfonic acid {3-[1-(4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-2,2-dimethyl-propyl]-phenyl}-amide
   Show/Hide
C32H37N3O7S
 1
1
IC50 = 2300 nM
   TI
   LI
   LO
   TS
CP0687918
3-(Cyclopropyl-phenyl-methyl)-4-hydroxy-11-propyl-6,7,8,9,10,11-hexahydro-5H-cyclonona[b]pyran-2-one
   Show/Hide
C25H32O3
 1
1
IC50 = 5300 nM
   TI
   LI
   LO
   TS
CP0671238
(E)-N-{3-[Cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydro-2H-cycloocta[b]pyran-3-yl)-methyl]-phenyl}-3-phenyl-acrylamide
   Show/Hide
C30H31NO4
 1
1
IC50 = 17100 nM
   TI
   LI
   LO
   TS
CP0806241
N-{3-[Cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydro-2H-cycloocta[b]pyran-3-yl)-methyl]-phenyl}-2-phenyl-acetamide
   Show/Hide
C29H31NO4
 1
1
IC50 = 17300 nM
   TI
   LI
   LO
   TS
CP0657801
1-{3-[Cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydro-2H-cycloocta[b]pyran-3-yl)-methyl]-phenyl}-3-phenyl-urea
   Show/Hide
C28H30N2O4
 1
1
IC50 = 21700 nM
   TI
   LI
   LO
   TS
CP0726144
N-{3-[Cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydro-2H-cycloocta[b]pyran-3-yl)-methyl]-phenyl}-4-fluoro-benzamide
   Show/Hide
C28H28FNO4
 1
1
IC50 = 21900 nM
   TI
   LI
   LO
   TS
CP0748757
N-{3-[Cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydro-2H-cycloocta[b]pyran-3-yl)-methyl]-phenyl}-benzamide
   Show/Hide
C28H29NO4
 1
1
IC50 = 23500 nM
   TI
   LI
   LO
   TS
CP0045716
(S)-2-{3-[Cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydro-2H-cycloocta[b]pyran-3-yl)-methyl]-phenylcarbamoyl}-pyrrolidine-1-carboxylic acid tert-butyl ester
   Show/Hide
C31H40N2O6
 1
1
IC50 = 29200 nM
   TI
   LI
   LO
   TS
CP0288634
({3-[Cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydro-2H-cycloocta[b]pyran-3-yl)-methyl]-phenylcarbamoyl}-methyl)-carbamic acid tert-butyl ester
   Show/Hide
C28H36N2O6
 1
1
IC50 = 29800 nM
   TI
   LI
   LO
   TS
CP0178456
((S)-1-{3-[Cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydro-2H-cycloocta[b]pyran-3-yl)-methyl]-phenylcarbamoyl}-ethyl)-carbamic acid tert-butyl ester
   Show/Hide
C29H38N2O6
 1
1
IC50 = 31800 nM
   TI
   LI
   LO
   TS
CP0309996
(2-{3-[Cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydro-2H-cycloocta[b]pyran-3-yl)-methyl]-phenylcarbamoyl}-ethyl)-carbamic acid tert-butyl ester
   Show/Hide
C29H38N2O6
 1
1
IC50 = 33400 nM
   TI
   LI
   LO
   TS
CP0045712
N-[3-[cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydrocycloocta[b]pyran-3-yl)methyl]phenyl]butanamide
   Show/Hide
C25H31NO4
 1
1
IC50 = 35100 nM
   TI
   LI
   LO
   TS
CP0212933
tert-butyl N-[(2S)-1-[3-[cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydrocycloocta[b]pyran-3-yl)methyl]anilino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]carbamate
   Show/Hide
C32H40N4O6
 1
1
IC50 = 45300 nM
   TI
   LI
   LO
   TS
CP0114373
(3-{3-[Cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydro-2H-cycloocta[b]pyran-3-yl)-methyl]-phenylcarbamoyl}-propyl)-carbamic acid tert-butyl ester
   Show/Hide
C30H40N2O6
 1
1
IC50 = 49500 nM
   TI
   LI
   LO
   TS
CP0740732
3-(Cyclopropyl-phenyl-methyl)-2,5,6,7,8,9,10,11-octahydro-cyclonona[b]pyran-4-ol
   Show/Hide
C22H28O2
 1
1
IC50 = 57300 nM
   TI
   LI
   LO
   TS
CP0178506
1-{3-[Cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydro-2H-cycloocta[b]pyran-3-yl)-methyl]-phenyl}-3-ethyl-urea
   Show/Hide
C24H30N2O4
 1
1
IC50 > 60000 nM
   TI
   LI
   LO
   TS
CP0189615
((R)-1-{3-[Cyclopropyl-(4-hydroxy-2-oxo-5,6,7,8,9,10-hexahydro-2H-cycloocta[b]pyran-3-yl)-methyl]-phenylcarbamoyl}-ethyl)-carbamic acid tert-butyl ester
   Show/Hide
C29H38N2O6
 1
1
IC50 > 60000 nM
   TI
   LI
   LO
   TS
CP0713211
1-Methyl-1H-imidazole-4-sulfonic acid {3-[1-((S)-4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C29H35N3O5S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0714228
5-Cyano-pyridine-2-sulfonic acid {3-[1-((S)-4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C31H33N3O5S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0771905
1-Methyl-1H-imidazole-4-sulfonic acid {3-[1-((R)-4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-propyl]-phenyl}-amide
   Show/Hide
C29H35N3O5S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0801491
1-Methyl-1H-imidazole-4-sulfonic acid {3-[cyclopropyl-(4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)-methyl]-phenyl}-amide
   Show/Hide
C30H35N3O5S
 1
1
IC50 < 1000 nM
   TI
   LI
   LO
   TS
CP0812076
1-Methyl-1H-imidazole-4-sulfonic acid {3-[cyclopropyl-(4-hydroxy-2-oxo-6,6-dipropyl-5,6-dihydro-2H-pyran-3-yl)-methyl]-phenyl}-amide
   Show/Hide
C25H33N3O5S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0353114
1-[4-[[5-[6-(methylamino)pyrazin-2-yl]-2-(4-morpholin-4-ylanilino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]piperidin-1-yl]prop-2-en-1-one
   Show/Hide
C29H33N9O3  1
1
GI50 = 232 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Peripheral blood)
Cell Line Name Organism Disease
SET-2 Homo sapiens (Human) Adult acute megakaryoblastic leukemia
Mono-Mac-6 Homo sapiens (Human) Adult acute monocytic leukemia
HL-60 Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-13 Homo sapiens (Human) Adult acute myeloid leukemia
OCI-AML-2 Homo sapiens (Human) Adult acute myeloid leukemia
HL-60/ADR Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-14 Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MDR Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MRP Homo sapiens (Human) Adult acute myeloid leukemia
NALM-6 Homo sapiens (Human) Adult B acute lymphoblastic leukemia
MOLT-4 Homo sapiens (Human) Adult T acute lymphoblastic leukemia
MOLT-4/CCR5 Homo sapiens (Human) Adult T acute lymphoblastic leukemia
Karpas-299 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
M-07e Homo sapiens (Human) Childhood acute megakaryoblastic leukemia
THP-1 Homo sapiens (Human) Childhood acute monocytic leukemia
MV4-11 Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual KO-STING Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Blue ISG Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-ASC-GFP Homo sapiens (Human) Childhood acute monocytic leukemia
PMNL Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Xblue Homo sapiens (Human) Childhood acute monocytic leukemia
SEM Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
SEMK2 Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Reh Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Jurkat Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
Jurkat E6.1 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-CEM Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF/VCR1000 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB100 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB500 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-SS Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
HPB-ALL Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-SB Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-T4 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
J-Lat 10.6 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
12D7-MDR1 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
MDR CCRF vcr1000 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
FGS7 Jurkat Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
EoL-1 Homo sapiens (Human) Chronic eosinophilic leukemia, not otherwise specified
CII Homo sapiens (Human) Chronic lymphocytic leukemia
Ku812 Homo sapiens (Human) Chronic myelogenous leukemia, BCR-ABL1 positive
Ri-1 Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
Daudi Homo sapiens (Human) EBV-related Burkitt lymphoma
HEL Homo sapiens (Human) Erythroleukemia
UKE-1 Homo sapiens (Human) Essential thrombocythemia
L-1236 Homo sapiens (Human) Hodgkin lymphoma
Granta-519 Homo sapiens (Human) Mantle cell lymphoma
JeKo-1 Homo sapiens (Human) Mantle cell lymphoma
Mino Homo sapiens (Human) Mantle cell lymphoma
HMC-1 Homo sapiens (Human) Mast cell leukemia
NK-92 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
NK Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
KHYG-1 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
RPMI-8226 Homo sapiens (Human) Plasma cell myeloma
OPM-2 Homo sapiens (Human) Plasma cell myeloma
U266B1 Homo sapiens (Human) Plasma cell myeloma
KMS-18 Homo sapiens (Human) Plasma cell myeloma
MM1.S Homo sapiens (Human) Plasma cell myeloma
MM1.R Homo sapiens (Human) Plasma cell myeloma
OPM-1 Homo sapiens (Human) Plasma cell myeloma
RPMI-8226/Dox40 Homo sapiens (Human) Plasma cell myeloma
HuT 78 Homo sapiens (Human) Sezary syndrome
CREM010i-SS9-1 Homo sapiens (Human) Sickle cell disease
RBL-1 Rattus norvegicus (Rat) Rat leukemia
RBL-2H3 Rattus norvegicus (Rat) Rat leukemia
LCL Orang Asli K28 Homo sapiens (Human) -
JY Homo sapiens (Human) -
C.M.L. Homo sapiens (Human) -
BON Homo sapiens (Human) -
PBMC iPSC #1 Homo sapiens (Human) -
LCL 721 Homo sapiens (Human) -